Purpose/Objective(s): To investigate a novel method of generating synthetic CT data (syn-CT) from high spectral and spatial resolution (HiSS) MRI for radiotherapy treatment planning. Materials/Methods: A phantom was constructed from a fresh beef shank containing muscle, fat, bone marrow, and cortical bone. The shank was embedded in a 1% agarose gel for spatial reproducibility from MRI to CT. A HiSS pulse sequence was used on a 1.5T Siemens Aera scanner to image a slice of the phantom with the following parameters: 1 x 1 x 4 mm 3 voxels, echo train length Z 89.9 ms, flip angle Z 50 , 11.1 Hz spectral resolution, and number of echoes Z 32. Data was processed offline [JMRI, 24, 1311[JMRI, 24, (2006] and images generated with pixel value proportional to water and fat peak height normalized by the spectral noise. The phantom was subsequently imaged with CT (1 x 1 x 3 mm 3 voxels) to use as a reference or "gold standard." A region-of-interest (ROI) was drawn for each tissue type (muscle, fat, bone marrow, and cortical bone) to determine whether these tissues have unique NMR characteristics. Water peak height versus fat peak height values were plotted on a pixel-by-pixel basis and the resulting plot was used to establish thresholds for labeling different tissues. The syn-CT image data was then generated based on a look-up table (LUT) of the mean HU in the various tissues. A body contour was generated by thresholding and pixels outside of this contour were set to -1000 Hounsfield Units (HU), corresponding to air. The syn-CT data was then rigidly registered to the real CT data. A subtraction image was generated to visualize the differences in images. Both synthetic and real CT images were converted to physical density using a LUT and radiological path length was calculated for rays emanating from a central point every 45 . Absolute differences in path length were calculated for each ray and the percent errors were reported. Results: The syn-CT image was qualitatively very similar to the real CT image with the largest differences at tissue interfaces. The overall mean radiological path length (g/cm 2 ) averaged over all angles was 6.7 for the synthetic CT and 6.8 for the real CT image. The mean percent error of the synthetic CT using the real CT as a gold standard was 2.3% AE 4.5 S.E. Conclusion: We have shown that a novel classification algorithm based on HiSS imaging is able to produce images with contrast similar to CT. Based on the calculations of radiological path length coupled with modern algorithms we expect that the dose calculated on a HiSS syn-CT image may be as accurate as that calculated using real CT. Further studies along with optimization of the pulse sequence are planned to address this important question.
Purpose/Objective(s): Late toxicity after tumor radiotherapy (RT) is considered to be determined by variations in multiple, low-penetrance genes each associated with moderate hazard ratios. Here we test the hypothesis that functional assays can distinguish subgroups of patients characterized by different mechanisms associated with patients' risk of late reaction after radiotherapy. Materials/Methods: Early-passage fibroblast cultures were established with informed consent from selected breast cancer patients with minimal (RT-resistant, n Z 15) or marked breast changes (RT-sensitive, n Z 19) after breast conserving therapy and were irradiated with 6MV X-rays in vitro. Residual DNA double-strand breaks (DSBs) were scored by 53BP1 foci 24h after irradiation with 4 Gy. Molecular markers p53 and Ki-67 were detected by immunofluorescence microscopy and the plating efficiency (PE) was determined by the colony formation assay. The nonparametric Wilcoxon/Mann-Whitney test, Spearman's rank correlation test, and a linear model, were used to test for statistical significance. Results: RT-sensitive patients showed significantly increased residual 53BP1 foci (2.48 AE 0.22 vs 1.86 AE 0.11 per cell; P Z 0.007) and an increased basal p53-positive fraction of cells without irradiation (7.1 AE 1.5 vs 2.5 AE 1.0 pct.; P Z 0.02). In addition, the subgroup of RT-sensitive patients with severe reaction relative to known risk factors (n Z 10) showed vigorous early upregulation of p53 2h after irradiation (P Z 0.005) in contrast to RT-sensitive patients with more moderate reaction (n Z 9) and RT-resistant patients. RT sensitivity showed no significant correlation with proliferation marker Ki-67. However, in the patient subgroup with low fibroblast proliferation activity (Ki-67 index), RT sensitivity correlated with basal levels of p53 (P < 0.001) and residual 53BP1 (P Z 0.013) whereas in the patient subgroup with higher Ki-67 index, severity correlated with early upregulation at 2h (P < 0.001) after irradiation. Multivariate analysis suggested that these potentially predictive parameters were largely independent. Conclusion: These results establish an association between the radiation response of fibroblasts and late reaction of the breast after RT and provide novel evidence for the existence of patient subgroups. We suggest that defects in the p53 stress response or DSB repair pathways may contribute to late reaction in RT-sensitive patients, possibly via increased misrepair and genomic instability. Functional studies may synergize with "omics" approaches and help unravel the mechanisms of normal-tissue reaction after RT. Purpose/Objective(s): Improvements in the treatment of breast cancer have resulted in a rise in the number of long-term survivors. However, late toxicities after radiotherapy (RT) still limit the dose that can be applied to tumors. Previously, a predictive test was proposed based on an association between high T-lymphocyte apoptosis after irradiation in vitro and reduced risk of overall late toxicity at two years follow-up in a cohort of mixed cancer types (Ozsahin et al. Clin. Cancer Res. 2005; 11:7426-7433) . The aim of the present study was to test the association for specific late endpoints (fibrosis, telangiectasia) in 252 breast cancer patients with 10 year clinical follow-up. Materials/Methods: A total of 252 female patients with histologically confirmed early breast cancer or in situ from the German ISE cohort received breast-conserving surgery and adjuvant RT. Peripheral blood was obtained from each patient, stored at room temperature for 24h, then 1:10 diluted in medium, irradiated (0 vs 8 Gy; 6 MV X-rays) and incubated at 37 C for 48h. The apoptosis rates of CD4 + T-helper and CD8 + cytotoxic T cells, as well as CD3 -/CD8 + NK cells were measured using three color flow cytometry (FACS). At follow-up after at least 10 years, RT-induced side effects were scored for each patient according to the LENT-SOMA scale.
The non-parametric Wilcoxon test was used for dichotomous (toxicity grade 0 + 1 vs grade 2 + 3) comparisons.
Results: Highly significant associations between the radiation-induced apoptosis rate and patient's fibrosis (P Z 0.011) or telangiectasia status (P < 0.001) were found for CD4 + cells. For CD8 + cells, apoptosis was only significant for telangiectasia (P Z 0.001) while NK cells (CD3/CD8 + ) showed a high rate of apoptosis which did not correlate with late side effects. Of note, for CD4 + cells, 77% (17/22) of patients with telangiectasia were in the lowest tertile of the samples ranked by apoptosis rates after in vitro irradiation, whereas only 53% (38/72) of patients with fibrosis were in this tertile. Conclusion: A correlation between the apoptosis rates after in vitro irradiation in CD4 + and CD8 + T cell populations and specific late effects of RT in breast cancer patients was demonstrated. In the present breast cancer patient cohort, the apoptosis rate in CD4 + T lymphocytes after in vitro irradiation was a better predictor for telangiectasia than for fibrosis. Currently, a multi-center prospective study ("REQUITE") funded by the European Union is being performed to validate the assay on a larger patient cohort including additional malignancies (prostate and lung cancer patients). 
